CULLINAN THERAPEUTICS INC. - COMMON STOCK
16.34
04-October-24 14:59:58
15 minutes delayed
Stocks
+0.24
+1.49%
Today's range
16.18 - 16.50
ISIN
N/A
Source
NASDAQ
-
17 Sep 2024 06:00:00 By Nasdaq GlobeNewswire
-
16 Sep 2024 06:00:00 By Nasdaq GlobeNewswire
-
14 Sep 2024 03:15:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
28 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
08 Aug 2024 06:00:01 By Nasdaq GlobeNewswire
-
01 Jun 2024 06:00:00 By Nasdaq GlobeNewswire
-
24 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
23 May 2024 16:04:38 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
15 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer
29 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
16 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
16 Apr 2024 05:59:00 By Nasdaq GlobeNewswire
-
14 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
01 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Participate in Upcoming Investor Conferences
27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
18 Dec 2023 15:53:03 By Nasdaq GlobeNewswire
-
14 Dec 2023 15:30:00 By Nasdaq GlobeNewswire
-
Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
08 Nov 2023 06:00:03 By Nasdaq GlobeNewswire
-
03 Nov 2023 11:01:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >